MCM
MESO

MAI Capital Management’s Mesoblast MESO Stock Holding History

MAI Capital Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$769 Hold
50
– – ﹤0.01% 4277
2025
Q4 		$902 Hold
50
– – ﹤0.01% 3660
2025
Q3 		$806 Sell
50
-173
-78% -$2.53K ﹤0.01% 3539
2025
Q2 		$2.43K Buy
+223
New +$2.5K ﹤0.01% 3347

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

MAI Capital Management's MESO Position: Q1 2026 in Review

MAI Capital Management held its Mesoblast (MESO) position steady in Q1 2026 at 50 shares worth $769. The position accounts for ﹤0.01% of the portfolio, ranked #4277.

MAI Capital Management first reported a position in MESO in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.43K in Q2 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • MAI Capital Management held 50 shares of Mesoblast worth $769 as of Q1 2026.
  • MAI Capital Management left its Mesoblast share count unchanged in Q1 2026.
  • Mesoblast made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4277 holding.
  • MAI Capital Management first reported a position in Mesoblast in Q2 2025 and has held it in 4 quarters since.
  • MAI Capital Management's Mesoblast position peaked at $2.43K in Q2 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.